Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 10.78x is 37% above its 5-year average of 7.85x, near the high end of its 5-year range (-17.02x–15.37x).
As of the fiscal period ended Tuesday, March 31, 2026. 0.08% above its 12-month average of 10.77x.
Reported quarterly interest coverage; no daily interpolation.
INTEREST COVERAGE RATIO
10.78x
INTEREST COVERAGE RATIO AVG TTM
10.77x
INTEREST COVERAGE RATIO AVG 3Y
9.24x
INTEREST COVERAGE RATIO AVG 5Y
9.53x
INTEREST COVERAGE RATIO AVG 10Y
9.68x
INTEREST COVERAGE RATIO AVG 15Y
11.68x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+0.08%
CURRENT VS 3Y AVG
+16.57%
CURRENT VS 5Y AVG
+13.07%
CURRENT VS 10Y AVG
+11.27%
CURRENT VS 15Y AVG
-7.75%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
6.77x
median of 73 covered companies
CURRENT VS SECTOR MEDIAN
+59.16%
vs the sector median at left
Gilead Sciences, Inc.
Market Cap
$161.62B
Interest Coverage Ratio
10.78x
TTM Avg
10.77x
3Y Avg
9.24x
5Y Avg
9.53x
Market Cap
$142.46B
Interest Coverage Ratio
5.78x
TTM Avg
5.55x
3Y Avg
10.96x
5Y Avg
11.04x
Market Cap
$183.31B
Interest Coverage Ratio
23.60x
TTM Avg
17.46x
3Y Avg
17.67x
5Y Avg
16.77x
Market Cap
$136.62B
Interest Coverage Ratio
19.38x
TTM Avg
19.02x
3Y Avg
23.18x
5Y Avg
23.65x
Market Cap
$134.51B
Interest Coverage Ratio
3.33x
TTM Avg
3.10x
3Y Avg
3.72x
5Y Avg
4.16x
Market Cap
$132.18B
Interest Coverage Ratio
8.11x
TTM Avg
7.03x
3Y Avg
5.51x
5Y Avg
4.49x
Market Cap
$132.10B
Interest Coverage Ratio
8.41x
TTM Avg
6.69x
3Y Avg
7.04x
5Y Avg
6.41x
Market Cap
$124.46B
Interest Coverage Ratio
8.05x
TTM Avg
10.41x
3Y Avg
10.98x
5Y Avg
10.79x
Market Cap
$124.10B
Interest Coverage Ratio
N/A
TTM Avg
55.58x
3Y Avg
55.58x
5Y Avg
55.58x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. (GILD) | $161.62B | 10.78x | 10.77x | 9.24x | 9.53x |
| Pfizer Inc. (PFE)vs › | $142.46B | 5.78x | 5.55x | 10.96x | 11.04x |
| Abbott Laboratories (ABT)vs › | $183.31B | 23.60x | 17.46x | 17.67x | 16.77x |
| Danaher Corporation (DHR)vs › | $136.62B | 19.38x | 19.02x | 23.18x | 23.65x |
| CVS Health Corp. (CVS)vs › | $134.51B | 3.33x | 3.10x | 3.72x | 4.16x |
| AstraZeneca PLC (AZN)vs › | $132.18B | 8.11x | 7.03x | 5.51x | 4.49x |
| Bristol-Myers Squibb Company (BMY)vs › | $132.10B | 8.41x | 6.69x | 7.04x | 6.41x |
| Stryker Corporation (SYK)vs › | $124.46B | 8.05x | 10.41x | 10.98x | 10.79x |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.10B | N/A | 55.58x | 55.58x | 55.58x |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $120.07B | 357.95x | 357.95x | 174.48x | 123.56x |
Interest Coverage
10.8x
Debt/Equity
1.08
Current Ratio
1.68
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | 10.78x |
| 2025-12-31 | 11.72x |
| 2025-09-30 | 13.00x |
| 2025-06-30 | 9.74x |
| 2025-03-31 | 8.60x |
| 2024-12-31 | 9.85x |
| 2024-09-30 | 3.73x |
| 2024-06-30 | 11.16x |
| 2024-03-31 | -17.02x |
| 2023-12-31 | 6.40x |
| 2023-09-30 | 11.31x |
| 2023-06-30 | 7.24x |
| 2023-03-31 | 7.41x |
| 2022-12-31 | 10.03x |
| 2022-09-30 | 12.39x |
| 2022-06-30 | 8.38x |
| 2022-03-31 | 0.83x |
| 2021-12-31 | 3.95x |
| 2021-09-30 | 15.37x |
| 2021-06-30 | 8.77x |
| 2021-03-31 | 11.25x |
| 2020-12-31 | 9.93x |
| 2020-09-30 | 8.48x |
| 2020-06-30 | -12.43x |
| 2020-03-31 | 9.97x |
| 2019-12-31 | 4.50x |
| 2019-09-30 | -5.89x |
| 2019-06-30 | 9.80x |
| 2019-03-31 | 8.81x |
| 2018-12-31 | 4.45x |
| 2018-09-30 | 9.94x |
| 2018-06-30 | 8.57x |
| 2018-03-31 | 7.42x |
| 2017-12-31 | 7.71x |
| 2017-09-30 | 13.10x |
| 2017-06-30 | 15.81x |
| 2017-03-31 | 14.43x |
| 2016-12-31 | 15.26x |
| 2016-09-30 | 18.18x |
| 2016-06-30 | 19.99x |
| 2016-03-31 | 20.22x |
| 2015-12-31 | 24.44x |
| 2015-09-30 | 33.85x |
| 2015-06-30 | 40.11x |
| 2015-03-31 | 35.10x |
| 2014-12-31 | 33.22x |
| 2014-09-30 | 33.46x |
| 2014-06-30 | 43.25x |
| 2014-03-31 | 40.04x |
| 2013-12-31 | 16.36x |
| 2013-09-30 | 15.52x |
| 2013-06-30 | 14.79x |
| 2013-03-31 | 12.54x |
| 2012-12-31 | 12.89x |
| 2012-09-30 | 11.69x |
| 2012-06-30 | 11.98x |
| 2012-03-31 | 8.23x |
| 2011-12-31 | 11.57x |
| 2011-09-30 | 23.29x |
| 2011-06-30 | 22.05x |
| 2011-03-31 | 21.88x |
| 2010-12-31 | 20.42x |
| 2010-09-30 | 29.12x |
| 2010-06-30 | 55.88x |
| 2010-03-31 | 68.48x |
| 2009-12-31 | 61.62x |
| 2009-09-30 | 51.95x |
| 2009-06-30 | 41.17x |
| 2009-03-31 | 48.49x |
| 2008-06-30 | 36.86x |
| 2008-03-31 | 41.75x |
